Seven data presentations and posters include studies evaluating enVista Aspireâ„¢ and IC-8® Aptheraâ„¢ intraocular lenses, XIIDRA® (lifitegrast ophthalmic solution) 5%, MIEBO® (perfluorohexyloctane ...
Aflibercept 8 mg cut RVO injections by up to 3 over 64 weeks in QUASAR, while a pair of additional posters show Amsler gaps ...
Name: [Landolt ring] An eye exam measures your visual acuity by checking whether you can see letters or symbols from a ...
When receiving the results of a school eye exam, many parents likely feel anxious when they see a note saying "uncorrected ...
Merck announced topline results from the pivotal Phase 2b/3 BRUNELLO trial in adults with diabetic macular edema (DME). BRUNELLO is the first of two Phase 2b/3 trials evaluating the safety and ...
At the Retina Society 59th Annual Scientific Meeting in Los Angeles, California, Christine Kay, MD, presented 4-year durability data for MCO-010 (Nanoscope Therapeutics). MCO-010 ...
At ESCRS 2026, Jascha Wendelstein, MD, noted standard ETDRS visual acuity testing misses functional differences between ...
At 6 months, third-generation Z+ IOL eyes achieved mean uncorrected visual acuity of 20/24 at distance and 20/26 at near under photopic conditions No serious adverse events or halos were reported; 79% ...
Post-LASIK night vision drops from Opus Genetics cleared two Phase 3 trials, reducing halos and glare, with FDA Fast Track status already granted.
Please provide your email address to receive an email when new articles are posted on . Researchers evaluated the effect of the EVO V4c ICL on dynamic visual acuity in 56 right eyes. Improvements may ...
The PIONEER program marks a key step toward potential first-in-class neuroprotection for optic neuritis and other neurological diseases, supported by positive Acuity Phase 2 data, FDA Breakthrough The ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Stock charts are crucial tools for investors. Stock charts are important today because ...